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The present review highlights critical issues related to cerebral metabolism following
traumatic brain injury (TBI) and the use of 13C labeled substrates and nuclear
magnetic resonance (NMR) spectroscopy to study these changes. First we address
some pathophysiologic factors contributing to metabolic dysfunction following TBI. We
then examine how 13C NMR spectroscopy strategies have been used to investigate
energy metabolism, neurotransmission, the intracellular redox state, and neuroglial
compartmentation following injury. 13C NMR spectroscopy studies of brain extracts from
animal models of TBI have revealed enhanced glycolytic production of lactate, evidence
of pentose phosphate pathway (PPP) activation, and alterations in neuronal and astrocyte
oxidative metabolism that are dependent on injury severity. Differential incorporation of
label into glutamate and glutamine from 13C labeled glucose or acetate also suggest
TBI-induced adaptations to the glutamate-glutamine cycle.
Keywords: acetate, glucose, glutamate-glutamine cycle, magnetic resonance spectroscopy, neuroglial
compartmentation, oxidative metabolism, pentose phosphate pathway
INTRODUCTION
A significant body of work has shown that traumatic brain injury
(TBI) initiates a cascade of cellular events including potassium
efflux (Katayama et al., 1990; Kawamata et al., 1995), Ca++ accu-
mulation (Fineman et al., 1993; Osteen et al., 2001), glutamate
release (Katayama et al., 1990; Nilsson et al., 1990; Rose et al.,
2002), and increased oxidative stress (Hall et al., 1993; Lewen and
Hillered, 1998; Vagnozzi et al., 1999; Tyurin et al., 2000;Marklund
et al., 2001) that contribute to reduced ATP production. In addi-
tion, TBI results in an immediate increase in cerebral metabolic
rates for glucose (CMRglc) (Yoshino et al., 1991; Sutton et al.,
1994; Lee et al., 1999; Kelly et al., 2000) that can endure for
days in TBI patients (Bergsneider et al., 1997). This increase is
thought to represent an increase in glycolysis (hyperglycolysis) in
an attempt to meet the cellular energy demand required to restore
ionic balance and maintain the neuronal membrane potential
(Hovda, 1996). Studies have shown that the duration and sever-
ity of regional decreases in ATP are dependent upon TBI severity
Abbreviations: ATP, adenosine triphosphate; Ca++, calcium; CCI, controlled
cortical impact; CMRglc, cerebral metabolic rate of glucose; FPI, fluid per-
cussion injury; G6PDH, glyceraldehyde-6-phosphate dehydrogenase; GAPDH,
glyceraldehyde-3-phosphate dehydrogenase; GC-MS, gas chromatography-mass
spectrometry; GLAST, glutamate-aspartate transporter; GLT-1, glutamate trans-
porter 1; GLT-1v, glutamate transporter 1 variant; NAD+, nicotinamide adenine
dinucleotide phosphate; NADP+, nicotinamide adenine dinucleotide phosphate;
NMR, nuclear magnetic resonance spectroscopy; PARP, poly(ADP) ribose poly-
merases; PC, pyruvate carboxylase; PDH, pyruvate dehydrogenase; PPP, pentose
phosphate pathway; TCA, tricarboxylic acid cycle; TBI, traumatic brain injury.
(Lee et al., 1999; Aoyama et al., 2008; Signoretti et al., 2010), and
during the post-injury period where ATP production is reduced,
secondary insults or activation of the injured brain can further
reduce ATP levels and result in secondary cellular damage (Ip
et al., 2003; Zanier et al., 2003; Aoyama et al., 2008). A secondary
and enduring reduction of CMRglc (metabolic “depression”) is
a common finding in models of experimental TBI (Hovda et al.,
1991; Yoshino et al., 1991; Sutton et al., 1994; Jiang et al., 2000;
Moore et al., 2000; Prins and Hovda, 2001) and after human TBI
(Langfitt et al., 1986; Yamaki et al., 1996; Bergsneider et al., 2000,
2001). Moreover, an increase in energy demand or decreased
glucose availability after TBI would potentially compromise neu-
ronal viability and functional outcomes (Vespa et al., 2003, 2007;
Parkin et al., 2005; Marcoux et al., 2008).
POTENTIAL FACTORS CONTRIBUTING TO THE METABOLIC
DEPRESSION AFTER TBI
Some underlying mechanisms responsible for the hypometabolic
response following TBI are the overproduction of reactive oxy-
gen and nitrogen species which can lead to poly(ADP) ribose
polymerases (PARP) activation (Laplaca et al., 1999; Clark et al.,
2001; Arundine et al., 2004; Mendez et al., 2004; Kauppinen,
2007; Besson, 2009) and related reductions of nicotinamide
adenine dinucleotide (NAD+) and nicotinamide adenine dinu-
cleotide phosphate (NADP+; Satchell et al., 2003; Clark et al.,
2007; Signoretti et al., 2010). Consequently, a diminished sup-
ply of reducing equivalents for oxidoreductive reactions involved
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in glucosemetabolism, such as glyceraldehyde-3-phosphate dehy-
drogenase (GAPDH) and pyruvate dehydrogenase (PDH), could
inhibit glycolysis and the entry of pyruvate into the TCA cycle
resulting in energy depletion and cell death. Reduced GAPDH
activity has also been shown to act as a “molecular switch”
resulting in increased flux of glucose into the PPP (Ralser et al.,
2007; Grant, 2008). Direct evidence for reduced activity of these
enzyme complexes following TBI is an active area of research,
and to date, studies have shown PDH nitrosylation (Opii et al.,
2007) and alterations in the expression and phosphorylation of
PDH E1alpha1 subunit (Sharma et al., 2009; Xing et al., 2009,
2012). Both increased intracellular Ca++ or PARP activity (Lai
et al., 2008) following TBI can also lead to an uncoupling of
the mitochondrial electron transport chain (Dugan et al., 1995)
and mitochondrial permeability transition (Gunter et al., 1994;
Schinder et al., 1996; Zamzami et al., 1997), with decreases in state
3 respiratory rates (Xiong et al., 1997, 1998; Verweij et al., 2000)
that would contribute to energy loss and cell death. Studies have
shown that PARP inhibitors can attenuate NAD+ reductions,
decrease neuronal damage, and improve behavioral outcome fol-
lowing experimental TBI (Laplaca et al., 2001; Komjati et al.,
2005; Clark et al., 2007; Besson, 2009).
13C STUDIES OF TBI
To more finely resolve the TBI-induced changes in glucose
metabolic pathways, a number of studies have employed the use
of stable isotopes (13C) of glucose, lactate and acetate to deter-
mine the metabolic fate of these fuels and characterize changes
in oxidative metabolism and neuroglia metabolic compartmen-
tation during the acute and hypometabolic periods following
experimental and clinical TBI (Bartnik et al., 2005, 2007; Dusick
et al., 2007; Gallagher et al., 2009; Scafidi et al., 2009; Bartnik-
Olson et al., 2010; Clausen et al., 2011). In most studies these
isotopes were used in conjunction with ex vivo 13C nuclear mag-
netic resonance (NMR) spectroscopy, which allows for the simul-
taneous assessment of multiple metabolic pathways. The primary
advantage of this technique arises from its ability to distinguish
13C incorporation into multiple metabolites as well as into the
specific carbon positions within the same metabolite, resulting
in a detailed analysis of the metabolic “fate” of the 13C label
(Bachelard and Badar-Goffer, 1993; Cruz and Cerdan, 1999). The
relative 13C enrichment at each carbon position and the ratios
between isotopomers of glutamate and glutamine gives additional
information regarding enzyme usage, neurotransmitter synthe-
sis, and neuroglia metabolic compartmentation (Badar-Goffer
et al., 1990; Shank et al., 1993; Hassel et al., 1995; Aureli et al.,
1997). As shown in Figure 1, 13C NMR spectroscopy can be
used to measure TBI-induced changes in glycolysis (13C lactate
labeling), oxidative metabolism within, and interactions between,
the neuron and astrocyte compartments (glutamate and glu-
tamine labeling). By using [1, 2 13C2] glucose as the substrate,
injury-induced changes in the activity of the pentose phosphate
pathway (PPP) can be assessed using the ratio between the lac-
tate labeled in two carbon positions (doublet) via glycolysis (C2
and C3) and lactate labeled in the singlet C3 carbon position
(Cruz et al., 1998; Lee et al., 1998). However, the formation
of a lactate C3 singlet also results via the pyruvate recycling
pathway (Hassel and Sonnewald, 1995). In contrast, lactate label-
ing using [1, 2 13C2] acetate is derived exclusively from the
pyruvate recycling pathway and comparisons between the lac-
tate C3 singlet/doublet ratio from [1, 2 13C2] glucose and the
lactate labeling from [1, 2 13C2] acetate could provide a valid
method for more accurately measuring the contribution of the
PPP to the post-injury response. The cytosolic NAD+/NADH
redox state of the injured tissue can be estimated by the ratio
of glutamate labeled in two carbon positions via glycolysis (C3
and C4) to the labeling of glutamate labeled in the C4 posi-
tion via the recycling of pyruvate from labeled oxaloacetate via
malic enzyme using either [1, 2 13C2] glucose or [1, 2 13C2]
acetate (ME; Cruz et al., 1998; Cerdan et al., 2006). This more
finely-grained approach to monitoring the fate of labeled fuels
provides an ideal platform from which to determine how fuel
supplementation after injury may prevent on-going metabolic
deficits.
EXPERIMENTAL MODELS USED IN 13C STUDIES OF TBI
To date 13C studies have been conducted using the lateral fluid
percussion injury (FPI) or the unilateral controlled cortical
impact (CCI) injury models of TBI. The FPI model can produce
a diffuse pattern of neuronal and axonal injury, while CCI is often
termed a more focal injury model due to the contusion induced
(Cernak, 2005) although widespread axonal injury occurs after
CCI (Hall et al., 2008). With moderate injury severity the period
of hyperglycolysis and the extent of ATP reduction in cortex is
reduced in the FPI model compared to CCI (Lee et al., 1999),
but in both TBI models a widespread reduction in CMRglc is
observed throughout the injured hemisphere within a few hours
(Hovda et al., 1991; Yoshino et al., 1991; Sutton et al., 1994;Moore
et al., 2000). Although CMRglc recovers to baseline within 10
days after FPI (Yoshino et al., 1991; Moore et al., 2000) substantial
reductions of CMRglc are still present by 15 days following CCI
injury (Moro et al., 2011).
GLYCOLYSIS AND PPP METABOLISM FOLLOWING TBI
Numerous experimental studies have reported an acute increase
in extracellular lactate levels consistent with hyperglycolysis fol-
lowing TBI (Inao et al., 1988; Kawamata et al., 1995; Chen et al.,
2000). In keeping with these observations, studies using ex vivo
13C NMR spectroscopy have reported increased 13C labeling of
lactate from 13C glucose in the injured cortex within the first
6 h following a CCI injury in both the adult (Bartnik et al.,
2005) and immature rat brain (Scafidi et al., 2009). In the adult
brain this increase was seen at 3.5 h after injury which then nor-
malized by 24 h (Bartnik et al., 2005). Increased lactate labeling
from 13C-labeled glucose was also detected by gas chromatog-
raphy/mass spectroscopy (GC-MS) from microdialysis samples
of CCI injured cerebral cortex in rats (Clausen et al., 2011)
and in blood samples from moderate-severe human TBI patients
(Dusick et al., 2007). In adult rats with FPI, lactate 13C labeling
was reduced at 24 h post-injury (Bartnik et al., 2007) indicating
reduced glucose metabolism via glycolysis in this more diffuse
TBImodel. It remains to be determined whether this finding is the
result of reduced GAPDH activity and whether similar findings
are replicated at all developmental stages.
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FIGURE 1 | Simplified illustration of the metabolic response to TBI as
determined by 13C NMR spectroscopy using [1, 2 13C2] glucose.
TBI-induced ion fluxes and neurotransmitter release can increase anaerobic
metabolism and initiate an injury cascade including increased
oxidative/nitrosative stress, PARP-1 activation, and NAD+ and/or NAPD+
reductions. These in turn are thought to result in the activation (+) or
inhibition (−) of enzymes contributing to the metabolic response to TBI (see
text). Using [1, 2 13C2] glucose as a precursor, 13C NMR spectroscopy can be
used to measure increases (↑) or decreases (↓) in glycolysis, the PPP,
oxidative metabolism in the TCA cycle, and the pyruvate recycling system by
monitoring the production of [2, 3 13C2] lactate, [2 13C] lactate, and [4, 5
13C2] glutamate and [4 13C] glutamate.
Ex vivo 13C NMR spectroscopy studies of cerebral cortex after
CCI or FPI using [1, 2 13C2] glucose also reported a significant
increase in lactate labeling via the PPP (Bartnik et al., 2005,
2007). This finding was supported by a clinical study of severe
TBI patients, where evidence of increased glucose metabolism via
the PPP was detected in blood samples using GC-MS following
an infusion of [1, 2 13C2] glucose (Dusick et al., 2007). The
PPP functions in producing reducing equivalents of NADPH
for biosynthetic reactions (Baquer et al., 1988) and it has been
demonstrated that this pathway has an enormous reserve capacity
that can be drawn on during periods of oxidative stress to act as a
proton donor during the redox cycling of glutathione (Hothersall
et al., 1982; Schrader et al., 1993). Peroxynitrite has been shown
to activate glucose-6-phosphate dehydrogenase (G6PDH), the
enzyme catalyzing the rate limiting step of the oxidative branch of
the PPP, resulting in the rapid activation of the PPP and increased
NADPH accumulation in astrocytes and neurons (Garcia-
Nogales et al., 2003). In addition, in vitro studies of neurons and
astrocytes in high glucose environments show increased PPP
activity and glutathione levels in astrocytes, which can reduce
levels of oxidative stress and protect neurons in mixed cultures
(Takahashi et al., 2012). Recently, it was shown that pyruvate
generated frommetabolism via the PPP can bemetabolized in the
TCA cycle and contributes to the formation of glutamate in neu-
rons (Brekke et al., 2012). Thus, it is tempting to hypothesize, but
remains to be proven that increased PPP activity following TBI
reflects a response by injured cells to combat oxidative/nitrosative
stress and/or provide additional substrates for oxidative
metabolism.
OXIDATIVE METABOLISM FOLLOWING TBI
As previously described, mitochondrial dysfunction is thought
to play a key role in the pathophysiology of TBI. Studies using
cytochrome C oxidase histochemistry as a measure of oxidative
phosphorylation on the mitochondrial membrane, show a dif-
fuse decrease in staining throughout the injured hemisphere of
both FPI (Hovda et al., 1991) and CCI (Moro and Sutton, 2010)
injured adult rats. Moreover, measurements of mitochondrial
respiration rates have shown TBI-induced reductions in mito-
chondrial state 3 respiratory rates in immature and adult rat
experimental models and humans (Xiong et al., 1997; Verweij
et al., 2000; Kilbaugh et al., 2011). Neuroprotective strategies
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targeting mitochondrial dysfunction such as cyclosporin A (or
its analog), oxidative/nitrosative species scavengers, or alternative
metabolic substrates to glucose have shown reduced cell death,
improvements in mitochondrial function, and/or functional
outcome (Fukushima et al., 2009; Moro and Sutton, 2010;
Mustafa et al., 2010; Kilbaugh et al., 2011; Readnower et al.,
2011; Singh et al., 2013). Mitochondrial dysfunction, specifi-
cally changes in the oxidative metabolism of metabolic fuels,
can be measured using 13C NMR spectroscopy by determin-
ing the amount of 13C incorporation into glutamate and glu-
tamine. However, oxidative metabolism in astrocytes and the
specific contribution of glutamine to metabolic compartmen-
tation is more accurately measured using acetate, a glial spe-
cific substrate (Waniewski and Martin, 1998; Lebon et al.,
2002; Deelchand et al., 2009; Shen, 2013) or [2 13C] glu-
cose that preferentially labels glutamine via pyruvate carboxylase
(PC).
Using an adult rat CCI injury model (Bartnik et al., 2005),
the amount of 13C label incorporated into the glutamate C2, C3,
and C4 isotopomers did not differ from naive, suggesting that
oxidative metabolism and the activity of PDH in glutamatergic
neurons is maintained in the injured cortex over the first 24 h after
injury. In the same study, a significant increase in 13C labeling of
the glutamine C3 isotopomer was detected at 3.5 h after injury.
Since the specific contribution of glutamine labeling via oxidative
metabolism in astrocytes is difficult to ascertain using [1, 2 13C2]
labeled glucose, this study could not clarify if the increased label-
ing of glutamine reflected the de novo synthesis of glutamine or
increased glutamate uptake by astrocytes in response to injury. In
support of the latter mechanism, increased glutamate metabolism
via the astrocytic TCA cycle occurs when extracellular glutamate
concentrations are increased (McKenna et al., 1996) and during
ischemia (Haberg et al., 1998; Pascual et al., 1998). Also, excito-
toxic injury in rats alters glutamate-glutamine cycle enzymes to
favor increased glutamine synthesis (Ramonet et al., 2004). In
contrast to CCI, adult rats with FPI showed reduced 13C label-
ing of all glutamate and glutamine isotopomers at 3.5 h post
injury, indicating reduced oxidative metabolism in both neurons
and astrocytes in the injured cortex (Bartnik et al., 2007). In this
model, the 13C labeling of glutamate returned to non-injury lev-
els by 24 h while reductions in glutamine labeling persisted. The
divergent pattern of 13C labeling between these two injury mod-
els likely represents previously reported differences in the extent
and severity of CMRglc changes in the two models (Yoshino
et al., 1991; Sutton et al., 1994; Lee et al., 1999; Moore et al.,
2000).
In contrast to what is observed in studies using adult
models, a 13C NMR spectroscopy study of the injured imma-
ture rat brain found increased labeling of glutamate and glu-
tamine C3 and C4 isotopomers at 5.5 and 6 h following CCI
injury (Scafidi et al., 2009). Scafidi et al. (2009) proposed
that there could be an accumulation of glutamate due to
impaired glutamate entry into the mitochondria via reduced
activity of the aspartate-glutamate carrier (McKenna et al.,
2006; McKenna, 2007), or reduced glutamate oxidation to
α-ketoglutarate via decreased activity of α-ketoglutarate dehy-
drogenase due to oxidative stress (Starkov et al., 2004). The
delayed increase in labeling also suggests a delay in the metabolic
response in the immature brain and highlight important
developmental differences in the response to injury (Scafidi et al.,
2009).
ASTROCYTE METABOLISM AND NEUROGLIA METABOLIC
COMPARTMENTATION FOLLOWING TBI
Astrocytes show pronounced changes in gene expression, cellular
hypertrophy and proliferation, in a degree relative to the sever-
ity of brain injury. Studies in both experimental and human
brain injury have demonstrated the presence of reactive astro-
cytes (Bourke et al., 1980; Cortez et al., 1989; Castejón, 1998).
Reactive astrocytes play dual roles following injury, one that
may result in a detrimental increase in glutamate excitotoxic-
ity or inflammation, the other being brain protection or repair
(Laird et al., 2008). A transient down regulation of glutamate
transporters GLT-1, GLT-1v, and GLAST on astrocytes after
experimental (Rao et al., 1998, 2001; Yi and Hazell, 2006) and
human TBI (van Landeghem et al., 2006; Beschorner et al., 2007)
may well contribute to the injury process. However, ablation
of reactive astrocytes following experimental CCI in transgenic
mice resulted in greater loss of cortical tissue and inflammation,
suggesting an essential protective role for astrocytes after TBI
(Myer et al., 2006).
Determining the role that astrocytes play in the metabolic
response to TBI is an important research direction. Astrocytes
play a pivotal role in meeting the energy requirements of neurons
through the glutamate-glutamine cycle that links the exchange
of glutamate and glutamine between glutamatergic neurons and
astrocytes (Van den Berg et al., 1969). Another proposed mech-
anism of metabolite trafficking between these cells is the lactate
shuttle, where astrocytes preferentially metabolize glucose via gly-
colysis and transfer lactate to neurons during high metabolic
demand (Magistretti and Pellerin, 1999; Bouzier-Sore et al., 2002;
Pellerin et al., 2007), although yet to be proven and a topic of
ongoing debate (Jolivet et al., 2010; Mangia et al., 2011). The net
synthesis of glutamate in neurons also requires a compensatory
flux of TCA cycle intermediates, notably glutamine from astro-
cytes (Schousboe et al., 1997), as neurons lack the capacity to
generate TCA cycle intermediates. This net synthesis of TCA cycle
intermediates, glutamate and glutamine depends upon the entry
of pyruvate, via an anaplerotic pathway, into the TCA cycle. In
the brain this is exclusively achieved by PC, an astrocyte specific
enzyme (Yu et al., 1983; Shank et al., 1985). Numerous in vitro
studies have shown that astrocytes supply TCA cycle substrates
to neurons during periods of glucose and/or oxygen deprivation
(Hertz, 2003; Bambrick et al., 2004; Peng et al., 2007), suggest-
ing that astrocytes may play an even greater nutritional role for
neurons in the injured state. Given the essential role of neu-
roglia metabolic coupling in normal brain, a greater appreciation
of the effect of TBI on metabolic coupling is an important and
necessary contribution to understanding the metabolic response
to TBI.
The 13C NMR studies detailed in section Glycolysis and PPP
Metabolism Following TBI suggest that neuroglia metabolic cou-
pling is altered in two different rat models of TBI. To more
clearly define the contribution of this metabolic coupling over
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FIGURE 2 | Simplified illustration of changes in neuroglial metabolic
coupling following FPI as determined using 13C labeled glucose and
acetate. Findings show reduced (−) glucose metabolism in both neuron
and astrocyte metabolic compartments, possibly due to reduced activity of
GAPDH and/or PDH. The capacity for oxidative metabolism was retained
(+) in the astrocyte compartment as 13C labeling was detected in glutamine
isotopomers resulting from acetate metabolism via the TCA cycle and PC.
Labeling of glutamate from 13C acetate indicates continued activity (+) of
the glutamate-glutamine cycle and phosphate activated glutaminase (PAG).
These findings could be interpreted to mean that astrocytes have a
supportive metabolic role to neurons following TBI.
the hypometabolic period, a 13C NMR spectroscopy study using
[1 13C] glucose, which is consumed in both neuronal and
glial compartments, and [1, 2 13C2] acetate, which is metabo-
lized solely within the glial compartment, was undertaken using
an adult rat FPI model (Bartnik-Olson et al., 2010). Figure 2
illustrates the metabolic alterations to neuronal and astrocyte
metabolism determined using this strategy. Similar to previous
findings, decreased 13C labeling of all glutamate isotopomers
from the metabolism of glucose was observed early post-injury,
but recovered over time, indicating that injury-induced decreases
in the oxidative metabolism of glucose in neurons is consistent
with the time course of reduced CMRglc following FPI (Yoshino
et al., 1991; Moore et al., 2000). Although the 13C labeling of
glutamine C4 from glucose in the first turn of the astrocyte
TCA cycle was reduced, the labeling of glutamine C2 and C3
remained unchanged, indicating that the metabolism of glucose
via PC was unaffected by FPI. In addition, the incorporation
of 13C label from acetate into glutamine and glutamate C4 was
maintained, indicating that oxidative metabolism in astrocytes
and the functional activity of the glutamate-glutamine cycle were
preserved during the hypometabolic period following FPI. 13C
labeling of glutamine from 13C acetate was also demonstrated fol-
lowing human TBI using microdialysis samples and 13C NMR
spectroscopy (Gallagher et al., 2009), although glutamate label-
ing was seen in only a few patients. It is important to note that
acetate enters the astrocyte TCA cycle as acetyl CoA, bypass-
ing any dysfunction in glycolysis or at the level of PDH, which
may relate to the ability of an acetate precursor to improve
ATP and improve motor performance after CCI (Arun et al.,
2010).
LIMITATIONS AND FUTURE DIRECTIONS
The studies reviewed above highlight alterations to a num-
ber of key metabolic processes during the period of metabolic
depression following experimental TBI. Although these studies
are valuable in their contributions linking the period of metabolic
depression to qualitative changes in a number of metabolic
processes, they are limited by their descriptive nature. In vivo
metabolic reactions are dynamic and future studies making use
of mathematical models to extract quantitative flux rates would
vastly improve our understanding of TBI-induced changes in
neuroglia compartmentation and neurotransmission. Moreover,
clinical (human) studies using dynamic 13C NMR spectroscopy is
a logical next step in advancing our understanding brain function
after TBI.
One goal of future animal and clinical 13C studies should
be to understand the cellular basis of metabolic alterations fol-
lowing TBI. It is important to establish how individual cell
types respond to TBI. For example, studies employing com-
partment specific labels (singly or in combination) could delin-
eate a cell-type specific preference for a metabolic fuel that
would preferentially enhance outcome. In addition, future stud-
ies of metabolic flux during the acute period of hypergly-
colysis could provide direct evidence of the metabolic forces
(increased neurotransmission and/or energetics) driving this
need. Moreover, comparisons between findings from the acute
period of hyperglycolysis and the period of metabolic depression
could establish key time points and potential targets for metabolic
intervention.
CONCLUSION
TBI induces multiple primary and secondary injury mecha-
nisms that can impact the supply of fuels and/or alter the
functions of metabolic enzymes and proteins which can lead
to deficits in energy availability. 13C NMR spectroscopy can
be utilized to probe multiple aspects of the metabolic response
to TBI, including changes in glycolysis, PPP activity, oxida-
tive metabolism, and neuroglial metabolic compartmentation.
As illustrated in the materials reviewed above, numerous exper-
imental treatments that improve cerebral metabolism, reduce
neuronal injury, and improve functional outcomes after TBI are
currently being investigated, and future studies using 13C NMR
spectroscopy to evaluate the metabolic responses to such treat-
ments should provide valuable insights into the mechanisms of
actions.
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